A landmark study presented at the International AIDS Conference in Rio de Janeiro marks a turning point in the long arc of the HIV epidemic: the people antiretroviral medicine saved are now growing old, and the systems built to save them were never designed to see them through. By 2040, more than half of all people living with HIV globally will be over fifty — a demographic shift that transforms a crisis of survival into a crisis of aging, falling most heavily on the low- and middle-income countries least equipped to meet it.
HIV's aging crisis: Older patients to outnumber younger by 2040
Millions of older adults living with HIV face inadequate healthcare systems unprepared to address their complex age-related medical needs, potentially compromising quality of life and health outcomes.
They age faster, and they age sicker.
Mark
Why does it matter that people with HIV are getting older? Isn't that actually a success story?
Mimi
It is a success, but success has consequences. The health systems that kept people alive were built for one job: suppress the virus. They weren't built to manage someone who is sixty-five, on antiretroviral therapy, and also has diabetes, heart disease, and early-stage cancer. Those are different problems requiring different expertise.
Mark
You mentioned people have a "biological debt." What does that mean exactly?
Mimi
It's the damage that lingers even after the virus is controlled. People who lived through the early pandemic, before good treatments existed, their immune systems were damaged in ways that don't fully heal. They carry chronic inflammation. They age faster than people without HIV, even on perfect treatment.
Mark
So the drugs work, but they don't fix everything?
Mimi
The drugs work brilliantly at one thing: keeping the virus suppressed. But HIV does damage beyond just the virus itself. And the drugs have their own long-term effects. You're managing multiple chronic conditions in a body that's aging faster than it should.
Mark
Where is this problem worst?
Mimi
In the poorest countries. Ninety-five percent of these older adults will be in low and middle-income countries. South Africa will see its over-fifty HIV population grow from 2.3 million to 3.9 million. These are places already stretched thin.
Mark
What would it take to fix this?
Mimi
You'd need to redesign HIV care from the ground up. Include screening for older adults. Expand clinical trials to include them. Train doctors to manage HIV alongside the diseases of aging. And start thinking about healthy aging the moment someone is diagnosed, not fifteen years later when they're already sick.
Mark
Is anyone doing that now?
Mimi
Not really. The infrastructure isn't there. The research isn't there. The awareness isn't there. That's why researchers are sounding the alarm now, before the crisis hits full force.
The Pulse
- A Lancet study warns that the global population of people over fifty living with HIV will nearly double by 2040, from 11.5 million to 20.2 million — a demographic wave already in motion.
- People with HIV age faster and sicker than the general population, accumulating diabetes, heart disease, cancer, and frailty at younger ages even when their virus is fully suppressed.
- Over 95% of these aging patients live in low- and middle-income countries whose health systems were built for acute viral management, not the layered complexity of geriatric chronic care.
- Older adults are routinely missed in HIV screening due to stigma and assumption, while clinical trials for prevention drugs have enrolled almost no elderly participants, leaving dangerous knowledge gaps.
- Researchers are calling for HIV care to be redesigned from the moment of diagnosis — embedding cardiovascular health, nutrition, and aging trajectories into treatment from the very start.
A landmark study presented at the International AIDS Conference in Rio de Janeiro marks a turning point in the long arc of the HIV epidemic: the people antiretroviral medicine saved are now growing old, and the systems built to save them were never designed to see them through. By 2040, more than half of all people living with HIV globally will be over fifty — a demographic shift that transforms a crisis of survival into a crisis of aging, falling most heavily on the low- and middle-income countries least equipped to meet it.
A warning delivered this week at the International AIDS Conference in Rio de Janeiro, drawn from research in The Lancet, describes a transformation quietly reshaping the HIV epidemic: by 2040, more than half of all people living with HIV globally will be over fifty years old. The shift — from 11.5 million older adults with HIV today to 20.2 million within fifteen years — is not a distant projection. It is already underway.
The burden will fall hardest where resources are thinnest. More than 95% of these aging patients will live in low- and middle-income countries. In South Africa alone, the number of people over fifty living with HIV will rise from 2.3 million to 3.9 million in the same period. By 2040, more than half of South Africans with HIV will be over fifty, and one in five will be over sixty-five.
The success of antiretroviral therapy created this moment. People who once faced death now live near-normal lifespans — but they do not age like everyone else. Yale's Amy Justice, one of the study's authors, is direct: the assumption that people on treatment live as others do is simply wrong. Even with the virus suppressed, they carry a disproportionate burden of chronic disease — heart disease, diabetes, cancer, liver disease — developing these conditions earlier and more severely than the general population.
Johns Hopkins researcher Keri Althoff describes it as a kind of biological debt. Many aging survivors carry the lasting damage of chronic inflammation and immune disruption from years before effective treatment existed. Their bodies are older than their age suggests.
The health systems meant to care for them were designed for a different problem — viral suppression, medication adherence, transmission prevention. They were not built to manage someone simultaneously navigating HIV, diabetes, cardiovascular disease, and the vulnerabilities of age. Screening for HIV in older adults remains rare, shaped by stigma and the false assumption that older people are not at risk. Clinical trials for prevention drugs have enrolled mostly younger people, leaving almost no safety data for elderly patients.
Justice argues the response must begin at diagnosis — guiding newly infected young people toward healthy aging from the start, embedding exercise, nutrition, and long-term cardiovascular care into HIV treatment itself. For health systems already strained by the basics, that reimagining may prove the most difficult challenge of all.
A quiet crisis is building inside the world's health systems, one that will reshape how we think about HIV care over the next fifteen years. By 2040, more than half of all people living with HIV globally will be over fifty years old. That shift—from 11.5 million older adults with HIV today to 20.2 million by the end of the next decade—was the warning delivered this week at the International AIDS Conference in Rio de Janeiro, based on research published in The Lancet. The numbers alone are staggering. But the real problem lies beneath them: almost no health system on earth is ready for what comes next.
The concentration of this crisis will fall hardest on the poorest parts of the world. More than ninety-five percent of these aging patients will live in low and middle-income countries—places already stretched thin by the basic work of keeping people alive. In South Africa alone, the number of people over fifty living with HIV will climb from 2.3 million to 3.9 million in the same fifteen-year window. Today, roughly one in three South Africans with HIV are over fifty. By 2040, that will be more than half. One in five will be over sixty-five.
For decades, HIV care has operated on a single, urgent logic: keep people alive. Get them diagnosed. Get them on antiretroviral drugs. Suppress the virus. By that measure, the system has succeeded beyond what seemed possible in the 1990s. People who take their medication faithfully can now expect near-normal lifespans. But that victory has created a new problem that medicine is only beginning to understand. As people with HIV grow older, they don't age like everyone else. They age faster, and they age sicker.
Amy Justice, a professor of public health at Yale University and one of the study's authors, put it plainly: the assumption that people on antiretroviral therapy live like anyone else is simply wrong. Even when the virus is suppressed, even when the drugs are working perfectly, people with HIV carry a higher burden of chronic disease than the general population. They develop diabetes, heart disease, cancer, and liver disease at younger ages and in greater numbers. Some of this burden comes from the virus itself, which leaves lasting damage even when controlled. Some comes from the drugs, which have their own long-term costs. And some comes from the accumulated weight of living through decades of illness and treatment.
Keri Althoff, from Johns Hopkins University's Bloomberg School of Public Health, described it as a kind of biological debt. Many of the people now aging with HIV are survivors of the pandemic's earliest years, when treatment was not available or came too late. Their bodies carry the scars of chronic inflammation and immune dysregulation that no amount of modern medication can fully erase. They are, in a real sense, older than their years.
The health systems designed to treat them were built for a different problem. They focus on viral suppression, on getting people to take their pills, on preventing transmission. They do not know how to manage the overlapping needs of someone who is simultaneously managing HIV, diabetes, heart disease, and the frailty that comes with age. Screening for HIV in older adults is rare, often overlooked because of stigma and the assumption that older people don't get infected. Clinical trials for prevention drugs have enrolled mostly younger people, leaving almost no safety data for the elderly. The research infrastructure itself is built for a younger population.
Justice argues that the solution must begin now, at the moment of diagnosis. Young people newly diagnosed with HIV should be guided toward healthy trajectories from the start—exercise, nutrition, cardiovascular health—so that they can age well over the decades ahead. But that requires a complete reimagining of how HIV care is delivered, one that treats aging not as something that happens later, but as something that begins the moment treatment begins. For health systems already struggling with the basics, that reimagining may be the hardest part of all.
Notable Quotes
There is a general belief that once you get people on antiretroviral therapy, their life expectancy is just like everyone else's. That is absolutely not the case.— Amy Justice, Yale University
People living with HIV are at higher risk of chronic conditions than people who are not living with HIV, even if they are on treatment and virally suppressed.— Amy Justice, Yale University
Want the full story?
Read the original at Business Day ↗
General News